Overview
Chronic Lymphocytic Leukemia Plasma | High-Quality Human Plasma from Chronic Lymphocytic Leukemia (CLL) Donors
Chronic Lymphocytic Leukemia Plasma is collected from donors clinically diagnosed with chronic lymphocytic leukemia (CLL) and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human CLL plasma supports research focused on biomarker discovery and monitoring, and treatment development for CLL.
Product Features
- Research Use Only (RUO)
- CLL plasma collected from clinically confirmed donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
Donor Metadata
- Verified CLL diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional CLL-specific metadata available
Applications
- Biomarker discovery and validation
- Cytokine and inflammation profiling
- Metabolomics and proteomics studies
- Therapeutic response research
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Chronic Lymphocytic Leukemia plasma is available in standard and custom volumes. For international orders or documentation requirements, please email [email protected] to ensure compatibility with your country’s regulations.
Protocols and Documentation
Document Type | Technical Document |
---|---|
PDF > | Plasma Isolation |
Publications
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.